David Rescott

Stock Analyst at Baird

(3.16)
# 1,184
Out of 5,012 analysts
69
Total ratings
48.21%
Success rate
2.3%
Average return

Stocks Rated by David Rescott

Boston Scientific
Oct 1, 2025
Maintains: Outperform
Price Target: $123$128
Current: $95.90
Upside: +33.47%
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94$96
Current: $98.33
Upside: -2.37%
Penumbra
Jul 30, 2025
Maintains: Buy
Price Target: $300$310
Current: $249.04
Upside: +24.48%
Edwards Lifesciences
Jul 25, 2025
Maintains: Neutral
Price Target: $78$79
Current: $76.72
Upside: +2.97%
Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $49.26
Upside: +76.61%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55$61
Current: $52.15
Upside: +16.97%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $82.70
Upside: +33.01%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600$575
Current: $440.94
Upside: +30.40%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25$26
Current: $15.33
Upside: +69.60%